Table 4. The genotype and allele frequencies of RAGE polymorphisms between chemotherapy responders and non-responders.

		Responder		Non-responder		global	adjusted	95%CI		X2	Adjusted P
						P	OR
−374T/A		N	%	N	%
	TT	18	13.53%	45	16.42%	0.167	1
	TA	82	61.65%	182	66.42%		1.13	0.61	2.06	0.15	0.7
	AA	33	24.81%	47	17.15%		1.76	0.87	3.55	2.47	0.116
	T	118	44.36%	272	49.64%		1
	A	148	55.64%	276	50.36%		1.24	0.92	1.66	2	0.158
−429T/C	TT	27	20.30%	42	15.33%	0.338	1
	TC	82	61.65%	188	68.61%		0.68	0.39	1.17	1.93	0.164
	CC	24	18.05%	44	16.06%		0.85	0.42	1.7	0.22	0.642
	T	136	51.13%	272	49.64%		1
	C	130	48.87%	276	50.36%		0.94	0.7	1.26	0.16	0.69
82G/S	GG	53	39.85%	73	26.64%	0.019	1
	GS	59	44.36%	137	50.00%		0.59	0.37	0.95	4.84	0.028
	SS	21	15.79%	64	23.36%		0.45	0.25	0.83	6.72	0.01
	G	165	62.03%	283	51.64%		1
	S	101	37.97%	265	48.36%		0.65	0.48	0.88	7.81	0.005